International journal of chronic obstructive pulmonary disease · 2025
Upregulation of ARHGAP18 by miR-613 Inhibits Cigarette Smoke Extract-Induced Apoptosis and Epithelial-Mesenchymal Transition in Bronchial Epithelial Cells.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fu Haifan, Liu Kai, Zheng Yamei, Zhao Jie, Xie Tian, Ding Yipeng
Аннотация
OBJECTIVE: Chronic Obstructive Pulmonary Disease (COPD) is a major chronic respiratory disease affecting human health worldwide. However, there is still a lack of effective drugs for treating COPD. This study is intended to explore the function and molecular mechanism of ARHGAP18 and miR-613 in COPD pathogenesis.
METHODS: We initially identified the marker gene closely related to epithelial dysfunction in COPD by integrating bioinformatic analyses. ARHGAP18 expression in CSE-induced bronchial epithelial cells (BEAS-2B) was detected by qRT-PCR. Besides, ARHGAP18 levels were modulated by lentivirus-mediated overexpression. Thereafter, cell variability, apoptosis, and migration were detected by CCK8, flow cytometry, and wound healing assay. IL-1β and TNF-α levels were examined by qRT-PCR. Epithelial-mesenchymal transition (EMT)-associated proteins were determined by Western blotting. The function of miR-613 in COPD was further detected. Functional rescue experiments were performed to determine the mechanism of ARHGAP18 in COPD.
RESULTS: Our study identified ARHGAP18 as the key gene associated with epithelial dysfunction in COPD. ARHGAP18 was downregulated in CSE-induced BEAS-2B cells. Overexpression of ARHGAP18 inhibited cell apoptosis of BEAS-2B cells and enhanced their proliferation and migration. Besides, ARHGAP18 overexpression reduced IL-1 β and TNF-α levels, enhanced E-cadherin expression, and suppressed Vimentin and N-cadherin expression. In contrast, miR-613 mimics exerted opposite effects. Furthermore, downregulation of ARHGAP1, mediated by miR-613 inhibitor promoted cell apoptosis and EMT of CSE-induced BEAS-2B cells, suggesting a regulatory role of miR-613 in COPD pathogenesis.
CONCLUSION: These findings highlight miR-613/ARHGAP18 axis as a critical regulator of epithelial dysfunction in COPD, offering a potential therapeutic target to counteract apoptosis, inflammation, and airway remodeling.
METHODS: We initially identified the marker gene closely related to epithelial dysfunction in COPD by integrating bioinformatic analyses. ARHGAP18 expression in CSE-induced bronchial epithelial cells (BEAS-2B) was detected by qRT-PCR. Besides, ARHGAP18 levels were modulated by lentivirus-mediated overexpression. Thereafter, cell variability, apoptosis, and migration were detected by CCK8, flow cytometry, and wound healing assay. IL-1β and TNF-α levels were examined by qRT-PCR. Epithelial-mesenchymal transition (EMT)-associated proteins were determined by Western blotting. The function of miR-613 in COPD was further detected. Functional rescue experiments were performed to determine the mechanism of ARHGAP18 in COPD.
RESULTS: Our study identified ARHGAP18 as the key gene associated with epithelial dysfunction in COPD. ARHGAP18 was downregulated in CSE-induced BEAS-2B cells. Overexpression of ARHGAP18 inhibited cell apoptosis of BEAS-2B cells and enhanced their proliferation and migration. Besides, ARHGAP18 overexpression reduced IL-1 β and TNF-α levels, enhanced E-cadherin expression, and suppressed Vimentin and N-cadherin expression. In contrast, miR-613 mimics exerted opposite effects. Furthermore, downregulation of ARHGAP1, mediated by miR-613 inhibitor promoted cell apoptosis and EMT of CSE-induced BEAS-2B cells, suggesting a regulatory role of miR-613 in COPD pathogenesis.
CONCLUSION: These findings highlight miR-613/ARHGAP18 axis as a critical regulator of epithelial dysfunction in COPD, offering a potential therapeutic target to counteract apoptosis, inflammation, and airway remodeling.